Pharmaceutical sciences

The Hub Craft and Legendary Paul Pierce will be launching TRUTH in Massachusetts

Retrieved on: 
Tuesday, June 15, 2021
Health sciences, Pharmaceutical sciences, Health care, Hub, Fitchburg, Dispensary, Medical cannabis

The Hub Craft and Paul Pierce collaborate to develop Cannabis products for statewide distribution in Massachusetts

Key Points: 
  • Fitchburg, Massachusetts--(Newsfile Corp. - June 15, 2021) - The Hub Craft, LLC, a Massachusetts cannabis company announced today that Paul Pierce, AKA The Truth, will launch his new product line exclusively licensed through The Hub Craft and distributed throughout the state of Massachusetts.
  • "I am excited to be part of The Hub Craft and the TRUTH brand coming to Massachusetts.
  • Get ready Massachusetts, because TRUTH is coming to several dispensaries within your state," says Pierce, who is also an investment partner in Hub Craft's Holyoke dispensary.
  • "Paul's personal battle with anxiety motivated him to create this premium brand," states Shivani Dallas, Chief Strategy Officer / The Hub Craft.

One Drop Appoints Former Sanofi Head of Diabetes Innovation, Carrie Siragusa, as VP of Commercial Strategy, Biosensor

Retrieved on: 
Tuesday, June 15, 2021
Health sciences, Companies, Pharmaceutical sciences, CAC 40, Sanofi, Siragusa, Pharmaceutical industry

Before joining One Drop, Siragusa led the Innovation and Diabetes Portfolio team at Sanofi, a leading global biopharmaceutical company focused on human health.

Key Points: 
  • Before joining One Drop, Siragusa led the Innovation and Diabetes Portfolio team at Sanofi, a leading global biopharmaceutical company focused on human health.
  • While at Sanofi, Siragusa was responsible for leading marketing for key diabetes brands and managing patient support programs.
  • Prior to Sanofi, Siragusa served as an auditor at EisnerAmper LLP, a leading full-service accounting and advisory firm.
  • For information on how One Drop can help your organization lower its cost of care, contact [email protected] .

Body and Mind Approved for Ohio Processing

Retrieved on: 
Friday, June 11, 2021
Cannabis, Cannabis smoking, Entheogens, Euphoriants, Dispensary, Health sciences, Health care, Pharmaceutical sciences

BaM and NMG Ohio, LLC have completed construction of the Ohio production facility and have received a certificate of occupancy and approval from the Department of Commerce to commence processing operations comprising manufacturing of extracted products, oils and edibles.

Key Points: 
  • BaM and NMG Ohio, LLC have completed construction of the Ohio production facility and have received a certificate of occupancy and approval from the Department of Commerce to commence processing operations comprising manufacturing of extracted products, oils and edibles.
  • The production facility is located next to the Body and Mind dispensary west of Cleveland and anticipates producing a wide variety of Body and Mind branded offerings for the Ohio market.
  • "As early dispensary operators in Ohio we've had significant feedback from customers and patients around non-flower choices and are looking forward to bringing our award-winning Body and Mind offerings to Ohio," stated Michael Mills, CEO of Body and Mind."
  • About Body and Mind Inc.
    BaM is an operations focused multi-state operator investing in high quality medical and recreational cannabis cultivation, production and retail.

Larimar Therapeutics to Present at the JMP Securities Life Sciences Conference

Retrieved on: 
Friday, June 11, 2021
Health sciences, Pharmaceutical sciences, Rare diseases, Trinucleotide repeat disorders, Health, Clinical pharmacology, Drug discovery, Pharmaceutics, Pharmacognosy, Friedreich's ataxia

Larimar Therapeutics, Inc.(Nasdaq: LRMR), is a clinical-stage biotechnology company focused on developing treatments for complex rare diseases.

Key Points: 
  • Larimar Therapeutics, Inc.(Nasdaq: LRMR), is a clinical-stage biotechnology company focused on developing treatments for complex rare diseases.
  • Larimars lead compound, CTI-1601, is currently being evaluated in a Phase 1 clinical program in theU.S.as a potential treatment for Friedreichs ataxia (FA).Larimaralso plans to use its intracellular delivery platform to design other fusion proteins to target additional rare diseases characterized by deficiencies in intracellular bioactive compounds.
  • For more information, please visit: https://larimartx.com .

Innocan Pharma's Liposome Platform Technology Demonstrates a 7-Week Prolonged Release of CBD into Bloodstream in Recent Animal Study

Retrieved on: 
Friday, June 11, 2021
Health sciences, Pharmaceutical sciences, Life sciences, Pharmaceutical industry, Pharmacology, Pharmacy, Liposome

Innocan believes this result to be extremely encouraging, given the 24-hour maximum CBD presence in the bloodstream when administered through traditional channels.

Key Points: 
  • Innocan believes this result to be extremely encouraging, given the 24-hour maximum CBD presence in the bloodstream when administered through traditional channels.
  • This unique liposome platform technology may have a wide range of applications, such as epilepsy, pain relief, inflammation and central nervous system disorders.
  • Innocan Pharma is a pharmaceutical tech company that focuses on the development of several drug delivery platforms containing CBD.
  • The founders and officers of Innocan Israel each have commercially successful track records in the pharmaceutical and technology sectors in Israel and globally.

Pharmaceutical Executive® Unveils the 21st Annual Pharma 50

Retrieved on: 
Thursday, June 10, 2021
Health sciences, Pharmaceutical sciences, Pharmaceutical industry, Pharmacology, Pharmacy, Health care, Pharmaceuticals policy, Draft:Sunshine Biopharma

Pharmaceutical Executive based rankings of the top 50 global biopharma leaders on companies' prescription drug sales.

Key Points: 
  • Pharmaceutical Executive based rankings of the top 50 global biopharma leaders on companies' prescription drug sales.
  • "With the end of the COVID-19 pandemic in sight, the Pharmaceutical Executive Pharma 50 list demonstrates the top sales performers that played a part in combating the public health crisis the industry has been facing," said Mike Hennessy Jr., president and CEO of MJH Life Sciences, parent company of Pharmaceutical Executive.
  • In addition to paying close attention to connected current trends, Pharmaceutical Executive based its rankings of the top 50 global biopharma leaders on the companies' full-year prescription drug sales in 2020.
  • Pharmaceutical Executive is a multimedia platform that offers news, opinions, analysis, features and executive profiles.

Japan Pharmaceutical Market Growth, Trends, COVID-19 Impact, and Forecasts 2021-2026 - ResearchAndMarkets.com

Retrieved on: 
Thursday, June 10, 2021
Health, Pharmaceutical, Health sciences, Pharmaceutical sciences, Health, Pharmaceutical industry, Pharmacology, Pharmacy, Pharmaceuticals policy, Pharmaceutical industry in China

The "Japan Pharmaceutical Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Japan Pharmaceutical Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)" report has been added to ResearchAndMarkets.com's offering.
  • Japan's pharmaceutical market has a strategic edge in its ability to make strong-quality pharmaceutical drugs and high-quality packaging technology.
  • Japan also has the greatest standard of quality assurance and quality control throughout the globe, as the Japanese pharmaceutical market aims to enhance the quality of pharmaceutical products across the globe.
  • Nevertheless, Japan's pharmaceutical market remains third largest market, behind the United States and China.

Ayr Wellness Announces the Expiration of HSR Act Waiting Period for the Proposed Acquisition of Garden State Dispensary

Retrieved on: 
Thursday, June 10, 2021
94th United States Congress, Hart–Scott–Rodino Antitrust Improvements Act, United States antitrust law, HSR, Dispensary, Cannabis, Health sciences, Pharmaceutical sciences, Health care

TORONTO, June 10, 2021 (GLOBE NEWSWIRE) -- Ayr Wellness Inc. (CSE: AYR.A, OTC: AYRWF) (Ayr or the Company), a leading vertically integrated cannabis multi-state operator, announced today the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (the HSR Act) in respect to its proposed acquisition of GSD NJ LLC (Garden State Dispensary or GSD) in New Jersey.

Key Points: 
  • TORONTO, June 10, 2021 (GLOBE NEWSWIRE) -- Ayr Wellness Inc. (CSE: AYR.A, OTC: AYRWF) (Ayr or the Company), a leading vertically integrated cannabis multi-state operator, announced today the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (the HSR Act) in respect to its proposed acquisition of GSD NJ LLC (Garden State Dispensary or GSD) in New Jersey.
  • As announced in December 2020, Ayr plans to acquire Garden State Dispensary (GSD), one of the 12 existing vertical permit holders in the State of New Jersey and one of the states original six alternative treatment centers (ATCs).
  • Including the maximum earn-out consideration, the Company estimates this represents a forward multiple of approximately 4x 2022 Adjusted EBITDA1.
  • Ayr strives to enrich consumers experience every day through the wellness and wonder of cannabis.

Advanced Container Technologies’ Exclusive Oklahoma Distributor Successfully Launches New Products and Services at CannaCon

Retrieved on: 
Wednesday, June 9, 2021
Cannabis in the United States, Cannabis dispensaries in the United States, Cannabis, Dispensary, Health sciences, Health care, Pharmaceutical sciences

CORONA, Calif., June 09, 2021 (GLOBE NEWSWIRE) -- Advanced Container Technologies, Inc (Ticker: ACTX), announced that Grassfire Distro its exclusive distributor for Oklahoma, launched several new products and services, and finalized a number of important deals at this years CannaCon Conference in the Oklahoma City.

Key Points: 
  • CORONA, Calif., June 09, 2021 (GLOBE NEWSWIRE) -- Advanced Container Technologies, Inc (Ticker: ACTX), announced that Grassfire Distro its exclusive distributor for Oklahoma, launched several new products and services, and finalized a number of important deals at this years CannaCon Conference in the Oklahoma City.
  • ACTX has an array of products and services designed to help legal cannabis dispensaries improve revenues and enhance customer loyalty.
  • The company selected Grassfire Distro to represent its products in Oklahoma due to Grassfires local market knowledge, established relationships, and boots on the ground.
  • Additionally, an annual jobs report shows that the legal cannabis industry in Oklahoma now employs over 17,000 people.

Leading MSO Columbia Care Revolutionizes Customer Shopping Experience with Launch of ‘Forage,’ an Online Cannabis Discovery Tool

Retrieved on: 
Wednesday, June 9, 2021
Retail, Alternative medicine, Health, Other Retail, Health sciences, Herbalism, Medicinal plants, Marketing, Pharmaceutical sciences, Brand management, Dispensary, Pharmacy, Customer experience, Cannabis, Medical cannabis

At Columbia Care, we strive to continue creating innovative ways to enhance the durability and individuality of the customer experience and ensure that our products offer the highest level of satisfaction and relevance, says Nicholas Vita, CEO of Columbia Care.

Key Points: 
  • At Columbia Care, we strive to continue creating innovative ways to enhance the durability and individuality of the customer experience and ensure that our products offer the highest level of satisfaction and relevance, says Nicholas Vita, CEO of Columbia Care.
  • Customers and patients will be able to access Forage anywhere by visiting forage.io as well as in select dispensaries across the country.
  • At the beginning of the pandemic, Columbia Care launched Virtual.Care, a virtual shopping experience that brings patients and customers face-to-face with cannabis professionals.
  • Columbia Care is one of the original providers of medical cannabis in the U.S. and continues to deliver industry-leading products and services.